Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» August 2011
August 2011
Acorda Therapeutics narrows 2nd quarter loss as Amprya sales, expenses climb
Acorda Therapeutics narrows 2nd quarter loss as Amprya sales, expenses climb
Yahoo/AP
Acorda Therapeutics
earnings
Court Allows Patents On Breast Cancer Genes
Court Allows Patents On Breast Cancer Genes
Pharmalot
genes
breast cancer
patents
Myriad Genetics
BRCA1
BRCA2
Celgene's Earnings Should Double by 2015
Celgene's Earnings Should Double by 2015
Seeking Alpha
Celgene
earnings
Active Biotech shares slump after Phase III result
Active Biotech shares slump after Phase III result
Marketwatch
Active Biotech
laquinimod
Teva Pharmaceuticals
MS
multiple sclerosis
Forest Labs' board urges rejection of Icahn slate
Forest Labs' board urges rejection of Icahn slate
Marketwatch
shareholders
Carl Icahn
Forest Labs
Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Seeking Alpha
Merck
Pfizer
Payer Negotiation is Next Up for AstraZeneca
Payer Negotiation is Next Up for AstraZeneca
WSJ Online
insurance
payer negotiation
AstraZeneca
Brilinta
Morphosys, Merck & Co. Sign Pact for HuCAL in Vaccine Research
Morphosys, Merck & Co. Sign Pact for HuCAL in Vaccine Research
Bloomberg
vaccines
MorphoSys
Merck
HuCAL
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45